相似文献
1
Crossing the Borders: An Integrated Approach to Myeloproliferative Neoplasms and Mastocytoses.
Cancers (Basel). 2021 Mar 24;13(7):1492. doi: 10.3390/cancers13071492.
2
Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.
Methods Mol Biol. 2017;1541:247-256. doi: 10.1007/978-1-4939-6703-2_20.
3
Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia.
Pathology. 1988 Jan;20(1):1-6. doi: 10.3109/00313028809085187.
4
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Curr Opin Hematol. 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565.
5
6
[Blood histamine level in chronic myeloproliferative diseases; a review].
Onkologie. 1979 Apr;2(2):70-4. doi: 10.1159/000214474.
7
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
Int J Mol Sci. 2021 Jan 11;22(2):659. doi: 10.3390/ijms22020659.
8
Current perspectives for the treatment of chronic myeloid leukemia.
Turk J Med Sci. 2019 Feb 11;49(1):1-10. doi: 10.3906/sag-1810-81.
9
Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Ann Hematol. 2005 Nov;84(12):767-70. doi: 10.1007/s00277-005-1056-y. Epub 2005 Nov 12.
10
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Exp Mol Pathol. 2018 Apr;104(2):130-133. doi: 10.1016/j.yexmp.2018.02.005. Epub 2018 Mar 1.
引用本文的文献
1
Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).
Int J Environ Res Public Health. 2021 Jul 16;18(14):7582. doi: 10.3390/ijerph18147582.
本文引用的文献
1
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
Mod Pathol. 2021 Jan;34(1):20-31. doi: 10.1038/s41379-020-0624-y. Epub 2020 Jul 21.
2
Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.
Int J Mol Sci. 2020 Jun 2;21(11):3987. doi: 10.3390/ijms21113987.
3
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
Blood. 2017 Feb 9;129(6):667-679. doi: 10.1182/blood-2016-10-695940. Epub 2016 Dec 27.
4
Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms.
Am J Clin Pathol. 2015 Aug;144(2):188-206. doi: 10.1309/AJCPZQK40JOZZZCC.
5
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.
Mod Pathol. 2013 Feb;26(2):204-12. doi: 10.1038/modpathol.2012.165. Epub 2012 Sep 28.
6
Chronic myeloid leukemia: an historical perspective.
Hematology Am Soc Hematol Educ Program. 2008:418. doi: 10.1182/asheducation-2008.1.418.
Zotero 插件